• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生殖细胞肿瘤原位(GCNIS)和其他组织学类型的睾丸癌中的细胞衰老。

Cellular Senescence in Germ Cell Neoplasia In Situ (GCNIS) and Other Histological Types of Testicular Cancer.

机构信息

Department of Urology, University of Patras, 26504 Patras, Greece.

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.

出版信息

Medicina (Kaunas). 2024 Jul 8;60(7):1108. doi: 10.3390/medicina60071108.

DOI:10.3390/medicina60071108
PMID:39064537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11278860/
Abstract

The presence and contribution of senescent cells in premalignant lesions is well documented, but not in germ cell neoplasia in situ. The purpose of this study is to identify the presence of senescent cells in pre-malignant testicular conditions and in different histological types of testicular cancer. Thirty patients who underwent orchiectomy due to testicular tumors were included. Formalin-fixed paraffin-embedded (FFPE) testicular tissue for each patient was available. Sections from these specimens were examined by immunohistochemical analysis with the following markers: GL13 for cellular senescence, p21 for cell cycle arrest, and Ki67 for cell proliferation. Thirteen (43.3%) suffered from seminoma with a mean total proportion of GCNIS senescence of 20.81 ± 6.81%. In the group of embryonal testicular tumors, nine (30%) patients were included, with an average rate of 6.64 ± 5.42% of senescent cells in GCNIS. One (3.3%) patient suffered from chondrosarcoma in which 7.9% of GL13+ cells were detected in GCNIS. Four (13.4%) patients suffered from teratoma and three (10%) from yolk sac tumors, while GCNIS senescence was detected in a range of 4.43 ± 1.78% and 3.76 ± 1.37%, respectively. Cellular senescence was detected in both germ cell neoplasia in situ and testicular cancer, but was more prevalent within the premalignant lesions.

摘要

衰老细胞在癌前病变中的存在和贡献已有充分的文献记载,但在生殖细胞原位肿瘤中则不然。本研究旨在确定衰老细胞在睾丸癌前病变和不同组织学类型的睾丸癌中的存在情况。

纳入了 30 名因睾丸肿瘤而行睾丸切除术的患者。每位患者的福尔马林固定石蜡包埋(FFPE)睾丸组织均可获得。通过免疫组织化学分析检查这些标本,使用以下标志物进行分析:GL13 用于细胞衰老,p21 用于细胞周期停滞,Ki67 用于细胞增殖。

13 名(43.3%)患者患有精原细胞瘤,GCNIS 衰老的总比例平均为 20.81±6.81%。在胚胎性睾丸肿瘤组中,纳入了 9 名(30%)患者,GCNIS 中衰老细胞的平均比例为 6.64±5.42%。1 名(3.3%)患者患有软骨肉瘤,在 GCNIS 中检测到 7.9%的 GL13+细胞。4 名(13.4%)患者患有畸胎瘤,3 名(10%)患者患有卵黄囊肿瘤,而 GCNIS 衰老的范围分别为 4.43±1.78%和 3.76±1.37%。

在生殖细胞原位肿瘤和睾丸癌中均检测到细胞衰老,但在癌前病变中更为常见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b9c/11278860/04eada4186af/medicina-60-01108-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b9c/11278860/ddb56cc19817/medicina-60-01108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b9c/11278860/17da8711ef91/medicina-60-01108-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b9c/11278860/04eada4186af/medicina-60-01108-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b9c/11278860/ddb56cc19817/medicina-60-01108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b9c/11278860/17da8711ef91/medicina-60-01108-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b9c/11278860/04eada4186af/medicina-60-01108-g003.jpg

相似文献

1
Cellular Senescence in Germ Cell Neoplasia In Situ (GCNIS) and Other Histological Types of Testicular Cancer.生殖细胞肿瘤原位(GCNIS)和其他组织学类型的睾丸癌中的细胞衰老。
Medicina (Kaunas). 2024 Jul 8;60(7):1108. doi: 10.3390/medicina60071108.
2
Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.人类睾丸生殖细胞肿瘤的特定免疫细胞和细胞因子特征
Hum Reprod. 2016 Oct;31(10):2192-202. doi: 10.1093/humrep/dew211. Epub 2016 Sep 8.
3
Testicular germ cell tumour arising 15 years after radiotherapy with 18 Gy for germ cell neoplasia in situ.放疗 18Gy 治疗生殖细胞原位肿瘤 15 年后发生的睾丸生殖细胞肿瘤。
Strahlenther Onkol. 2023 Mar;199(3):322-326. doi: 10.1007/s00066-022-02025-x. Epub 2022 Nov 28.
4
The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.癌基因 Gankyrin 在睾丸癌中表达,并有助于胚胎癌细胞对顺铂的敏感性。
BMC Cancer. 2019 Nov 19;19(1):1124. doi: 10.1186/s12885-019-6340-7.
5
Management and outcome of paediatric testicular tumours - A 20 year experience.小儿睾丸肿瘤的治疗和预后——20 年经验总结。
J Pediatr Surg. 2021 Nov;56(11):2032-2036. doi: 10.1016/j.jpedsurg.2021.02.063. Epub 2021 Mar 5.
6
[Testicular germ cell tumors: Histopathological and molecular features].[睾丸生殖细胞肿瘤:组织病理学和分子特征]
Bull Cancer. 2019 Apr;106(4):328-341. doi: 10.1016/j.bulcan.2019.02.004. Epub 2019 Mar 21.
7
Beneficial value of testicular sperm extraction-AgarCyto in addition to the standard testicular biopsy for diagnosis of testicular germ cell tumors in nonobstructive azoospermia.睾丸精子提取-琼脂细胞法除了用于标准睾丸活检以诊断非梗阻性无精子症患者的睾丸生殖细胞肿瘤外的有益价值。
Fertil Steril. 2016 Feb;105(2):308-14.e1. doi: 10.1016/j.fertnstert.2015.09.040. Epub 2015 Oct 19.
8
Testicular Tumors: A Contemporary Update on Morphologic, Immunohistochemical and Molecular Features.睾丸肿瘤:形态学、免疫组织化学和分子特征的当代更新。
Adv Anat Pathol. 2021 Jul 1;28(4):258-275. doi: 10.1097/PAP.0000000000000302.
9
[Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].免疫组织化学和荧光原位杂交技术对Ⅱ型睾丸生殖细胞肿瘤12号染色体短臂的诊断价值
Zhonghua Nan Ke Xue. 2016 Aug;22(8):692-697.
10
Intratubular Teratoma: A Rare Form of Testicular Germ Cell Neoplasia.小管内畸胎瘤:睾丸生殖细胞肿瘤的一种罕见形式。
Int J Surg Pathol. 2019 Aug;27(5):556-560. doi: 10.1177/1066896919836491. Epub 2019 Mar 24.

本文引用的文献

1
A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells.一种荧光团标记的试剂,可实现衰老细胞的快速检测、分离和活细胞示踪。
Mol Cell. 2023 Oct 5;83(19):3558-3573.e7. doi: 10.1016/j.molcel.2023.09.006.
2
Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson's Disease.衰老细胞清除剂:开辟药物研发新途径,寻找帕金森病新疗法。
Drug Discov Today. 2023 Jun;28(6):103582. doi: 10.1016/j.drudis.2023.103582. Epub 2023 Apr 5.
3
Seminoma subtypes differ in the organization and functional state of the immune microenvironment.
精原细胞瘤亚型在免疫微环境的组织和功能状态方面存在差异。
3 Biotech. 2023 Mar;13(3):110. doi: 10.1007/s13205-023-03530-1. Epub 2023 Mar 2.
4
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability.特发性肺纤维化的衰老细胞清除剂达沙替尼和槲皮素:一项 I 期、单盲、单中心、随机、安慰剂对照的可行性和耐受性初步试验结果。
EBioMedicine. 2023 Apr;90:104481. doi: 10.1016/j.ebiom.2023.104481. Epub 2023 Feb 28.
5
Germ cell neoplasms of the testis: Update for 2022.睾丸生殖细胞肿瘤:2022年更新
Semin Diagn Pathol. 2023 Jan;40(1):2-21. doi: 10.1053/j.semdp.2022.07.001. Epub 2022 Jul 7.
6
A recurrent chromosomal inversion suffices for driving escape from oncogene-induced senescence via subTAD reorganization.一段反复出现的染色体倒位足以通过亚染色质区隔重组驱动逃避致癌基因诱导的衰老。
Mol Cell. 2021 Dec 2;81(23):4907-4923.e8. doi: 10.1016/j.molcel.2021.10.017. Epub 2021 Nov 17.
7
Algorithmic assessment of cellular senescence in experimental and clinical specimens.实验和临床样本中细胞衰老的算法评估
Nat Protoc. 2021 May;16(5):2471-2498. doi: 10.1038/s41596-021-00505-5. Epub 2021 Apr 28.
8
Therapeutic Potential of Senolytics in Cardiovascular Disease.衰老细胞清除疗法在心血管疾病中的治疗潜力。
Cardiovasc Drugs Ther. 2022 Feb;36(1):187-196. doi: 10.1007/s10557-020-07075-w. Epub 2020 Sep 26.
9
Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-X -BAX interaction.通过干扰 BCL-X -BAX 相互作用,衰老诱导肿瘤细胞的清除剂 ABT-263。
Mol Oncol. 2020 Oct;14(10):2504-2519. doi: 10.1002/1878-0261.12761. Epub 2020 Aug 5.
10
DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.DNA 损伤而非恩杂鲁胺诱导的前列腺癌细胞衰老促进了衰老选择性 Bcl-xL 抑制剂的敏感性。
Cells. 2020 Jul 1;9(7):1593. doi: 10.3390/cells9071593.